The current status of miRNA in urinary bladder cancer: A minireview and strength, weakness, opportunity, and threat analysis DOI Creative Commons

R. M. Tripathy,

Lalit Kumar,

Sukhad Kural

et al.

Indian Journal of Urology, Journal Year: 2025, Volume and Issue: 41(2), P. 98 - 103

Published: April 1, 2025

ABSTRACT MicroRNAs, small noncoding RNA molecules, are critical in modulating gene expression and contribute substantially to the initiation progression of urinary bladder cancer (UBCa), a major malignancy affecting people globally. UBCa is known for its high recurrence rates significant heterogeneity. The stability miRNAs body fluids such as urine blood excellent potential noninvasive markers early detection, monitoring treatment progress, predicting outcomes patients with UBCa. In addition, could also improve effectiveness immunotherapy support development personalized strategies. Despite their potential, challenges variability shortcomings delivery systems must be carefully addressed. This strength, weakness, opportunity, threat (SWOT) analysis highlights crucial role explores advancing precision oncology.

Language: Английский

The current status of miRNA in urinary bladder cancer: A minireview and strength, weakness, opportunity, and threat analysis DOI Creative Commons

R. M. Tripathy,

Lalit Kumar,

Sukhad Kural

et al.

Indian Journal of Urology, Journal Year: 2025, Volume and Issue: 41(2), P. 98 - 103

Published: April 1, 2025

ABSTRACT MicroRNAs, small noncoding RNA molecules, are critical in modulating gene expression and contribute substantially to the initiation progression of urinary bladder cancer (UBCa), a major malignancy affecting people globally. UBCa is known for its high recurrence rates significant heterogeneity. The stability miRNAs body fluids such as urine blood excellent potential noninvasive markers early detection, monitoring treatment progress, predicting outcomes patients with UBCa. In addition, could also improve effectiveness immunotherapy support development personalized strategies. Despite their potential, challenges variability shortcomings delivery systems must be carefully addressed. This strength, weakness, opportunity, threat (SWOT) analysis highlights crucial role explores advancing precision oncology.

Language: Английский

Citations

1